Semax (6-Imino-6-Nor-Leu-D-Phe-Lys-Arg-Gly-Pro-NH₂)

Semax is a potent research-use-only peptide with a history rooted in neurochemical and cognitive research. Structurally related to the naturally occurring peptide arginine vasopressin (AVP), Semax exhibits selective modulation of neurotrophic pathways and cognitive enhancement properties in preclinical studies.

Research Context

Semax was first synthesized in the mid-1980s as part of studies investigating peptide-based neuroprotection and cognitive enhancement. Initial research focused on its potential role in enhancing memory formation, reducing neuroinflammation, and supporting neurogenesis. Over time, it has emerged as a key compound in the study of neuroplasticity, particularly in rodent models of aging and neurodegenerative conditions.

Research Overview

Semax operates via interactions with the arginine vasopressin (AVP) receptors and related neurotrophic pathways, including the PI3K/Akt/mTOR and MAPK signaling cascades. Preclinical studies have demonstrated its ability to enhance synaptic plasticity, support long-term potentiation (LTP), and mitigate oxidative stress. It has also been explored for its potential neuroprotective effects in models of stroke, Alzheimer’s disease, and traumatic brain injury, though these applications remain experimental.

Key Research Focus Areas

• Cognitive Enhancement: Investigated in rodent models for its role in improving memory retention and spatial learning, particularly in aging and neurotoxic conditions.
• Neuroprotection: Studied for its ability to reduce neuronal apoptosis in ischemic and neurodegenerative models.
• Anti-Inflammatory Effects: Examined for its modulation of glial cell activation and cytokine expression in neuroinflammatory diseases.
• Neurogenesis and Synaptogenesis: Investigated in the hippocampus and cortex for its role in enhancing dendritic spine formation and neuronal regeneration.
• Aging and Longevity: Explored in rodent models of senescence for its potential to delay cognitive decline and preserve neurovascular integrity.

Safety and Compliance

Semax is a highly selective peptide with minimal off-target effects in preclinical studies. However, its long-term safety in human or animal systems remains unproven outside of controlled research settings. Due to its neuroactive properties, it should only be handled by trained personnel under sterile conditions. This product is intended for use in accredited research institutions and academic laboratories only.

For research use only. Not for human or animal consumption.